ArticleNeurology2021

Andexanet Alfa for Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: Does a Specific Reversal Agent Justify Its Cost?

Nikhil Patel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.